Immunogenicity of Plasmodium vivax merozoite surface protein-9 recombinant proteins expressed in E. coli. (Q47664368)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15121316%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Immunogenicity of Plasmodium vivax merozoite surface protein-9 recombinant proteins expressed in E. coli (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15121316%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

0 references

0 references

Joseli Oliveira-Ferreira

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15121316%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Alberto Moreno

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15121316%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

3

John W Barnwell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15121316%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Esmeralda Vargas-Serrato

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15121316%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Mary R Galinski

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15121316%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

language of work or name

English

0 references

publication date

1 May 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15121316%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15121316%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15121316%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

15-16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15121316%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

2023-2030

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15121316%20AND%20SRC:MED&resulttype=core&format=json

Chloroquine resistance in Plasmodium vivax

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.021

High dose of primaquine in primaquine resistant vivax malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.021

Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.021

Plasmodium vivax merozoite surface protein-3 contains coiled-coil motifs in an alanine-rich central domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.021

The Plasmodium vivax homologues of merozoite surface proteins 4 and 5 from Plasmodium falciparum are expressed at different locations in the merozoite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.021

Merozoite surface protein-9 of Plasmodium vivax and related simian malaria parasites is orthologous to p101/ABRA of P. falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.021

Plasmodium vivax malaria vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.021

Age-acquired immunity to a Plasmodium vivax invasion ligand, the duffy binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.021

Mycobacterium bovis bacillus calmette-guérin induces protective immunity against infection by Plasmodium yoelii at blood-stage depending on shifting immunity toward Th1 type and inducing protective IgG2a after the parasite infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.021

Long-lasting protective immunity against rodent malaria parasite infection at the blood stage by recombinant BCG secreting merozoite surface protein-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.021

Immunogenicity of recombinant fragments of Plasmodium falciparum acidic basic repeat antigen produced in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.021

Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.021

inferred from DOI database lookup

7 January 2021

based on heuristic

Testing the efficacy of a recombinant merozoite surface protein (MSP-1(19) of Plasmodium vivax in Saimiri boliviensis monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.021